Rockwell Medical Acquires Vantive's Global HD Business for $125M
Rockwell Medical, Inc. announced a transformational acquisition of Vantive Limited's global hemodialysis business for a base purchase price of $125 million. The deal, expected to close mid-2027, includes Vantive's concentrates, machines, water treatment systems, and related services, establishing Rockwell Medical as a major global player in the hemodialysis market. The combined entity is projected to generate annual revenues between $400 million and $450 million. The acquisition will be financed through seller financing, including term loans and a convertible note, with potential for additional contingent payments. Rockwell Medical has withdrawn its 2026 financial guidance due to anticipated transaction-related expenses.
Key Highlights
- Rockwell Medical to acquire Vantive's global hemodialysis business for $125M base price.
- Acquisition includes concentrates, machines, water systems, and related services.
- Combined business projected to generate annual revenue between $400M and $450M.
- Financing includes $100M in seller-financed term loans and a $25M convertible note.
- Potential for up to $45M in additional contingent consideration based on performance.
- Transaction expected to close mid-2027, subject to regulatory approvals.
- Rockwell Medical withdraws 2026 guidance due to transaction-related expenses.
Price Impact
More from RMTI